March 8, 2021 | HealthClot

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract …

By HealthClot Moderator
March 8, 2021
0

Steba Biotech receives FDA Orphan Drug Designation for Padeliporfin ImPACT in Upper Tract … Designation confers advantages including marketing exclusivity and tax credits Padeliporfin ImPACT pivotal Phase 3 trial in UTUC to start end Q1 2021 LUXEMBOURG, March 08, 2021 (GLOBE NEWSWIRE) — Steba Biotech, the IMmune Photo Activate Cancer Treatment (IMPACT) specialist today announces the […]

Third of patients with rare cancer initially misdiagnosed

By HealthClot Moderator
March 8, 2021
0

Third of patients with rare cancer initially misdiagnosed Third of patients with rare cancer initially misdiagnosed | NL Times Skip to main content Main navigation Published at Mon, 08 Mar 2021 08:15:00 +0000

Colon cancer screenings: ‘The only wrong option is to do nothing,’ doctor says

By HealthClot Moderator
March 8, 2021
0

Colon cancer screenings: ‘The only wrong option is to do nothing,’ doctor says March is Colorectal Cancer Awareness Month, and doctors want the public to know about the importance of screening. Colorectal cancer is the second-leading cause of cancer death in the U.S. for men and women combined. “The five-year survival rate for colorectal cancer […]

New CAR T-Cell therapy extends remission in heavily relapsed multiple myeloma patients

By HealthClot Moderator
March 8, 2021
0

New CAR T-Cell therapy extends remission in heavily relapsed multiple myeloma patients IMAGE: A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical… view more Credit: UT Southwestern Medical Center DALLAS – March 8, 2021 – A […]

Expert Says CAR T-Cell Therapies Could Make Cancer a Chronic Disease

By HealthClot Moderator
March 8, 2021
0

Expert Says CAR T-Cell Therapies Could Make Cancer a Chronic Disease In a recent interview with Pharmacy Times, Lee Greenberger, PhD, chief medical officer of the Leukemia and Lymphoma Society, said the development of chimeric antigen receptor (CAR) T-cell therapies is a major step for the treatment of some cancers. In a recent interview with […]